Detalles de la búsqueda
1.
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study.
Int J Neuropsychopharmacol
; 24(12): 965-976, 2021 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324636
2.
Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019.
BMC Psychiatry
; 20(1): 4, 2020 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900133
3.
Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR.
Pharm Res
; 29(9): 2555-64, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22618801
4.
Validation of a bowel function diary for assessing opioid-induced constipation.
Am J Gastroenterol
; 106(3): 497-506, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21063394
5.
Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting.
Curr Med Res Opin
; 37(8): 1377-1384, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818238
6.
Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States.
BMC Palliat Care
; 9: 14, 2010 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20565876
7.
Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.
Clin Drug Investig
; 30(8): 489-505, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20586515
8.
Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain.
Pain Pract
; 10(5): 416-27, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20602712
9.
First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18.
J Pain Res
; 12: 1925-1936, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31303784
10.
Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach.
Clin Drug Investig
; 37(3): 273-283, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853999
11.
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system.
Pain
; 157(5): 1056-1064, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27058680
12.
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
Pain
; 157(9): 1851-1871, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27152687
13.
Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain.
J Opioid Manag
; 11(5): 393-403, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26535967
14.
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
Clin Ther
; 37(11): 2420-38, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26428249
15.
Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
J Opioid Manag
; 11(3): 211-27, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25985806
16.
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy.
Clin Drug Investig
; 35(2): 95-108, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25503082
17.
Evaluation of blood pressure and heart rate in patients with hypertension who received tapentadol extended release for chronic pain: a post hoc, pooled data analysis.
Clin Drug Investig
; 34(8): 565-76, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24916058
18.
Safety and tolerability of tapentadol extended release in moderate to severe chronic osteoarthritis or low back pain management: pooled analysis of randomized controlled trials.
Adv Ther
; 31(6): 604-20, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24985410
19.
Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release.
Clin Drug Investig
; 34(7): 501-11, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24906437
20.
Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: results of in vitro laboratory analyses.
J Opioid Manag
; 10(3): 149-58, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24944065